Due to COVID-19, HCA’s lobby is closed. Learn more about HCA's customer service options during the pandemic.
Apple Health Preferred Drug List (PDL)
The Health Care Authority (HCA) implemented the Apple Health Preferred Drug List (PDL) on January 1, 2018. All managed care plans and the fee-for-service program serving Apple Health clients use this PDL.
Preferred drugs within a chosen therapeutic class are selected based on clinical evidence of safety, efficacy, and effectiveness. The drugs within a chosen therapeutic class are evaluated by the Drug Use Review Board, which makes recommendations to HCA regarding the selection of the preferred drugs.
On this page
The Apple Health PDL has products listed in groups by drug class. To obtain authorization for a nonpreferred drug, a client must have tried and failed, or is intolerant to, a designated number of preferred drugs within the drug class unless contraindicated or not clinically appropriate. The designated number of preferred drugs is listed on the Apple Health PDL.
In addition to approval criteria for nonpreferred products, some drugs have additional criteria that must be met. The requirement for additional criteria is noted in the columns on the Apple Health PDL.
Note: For continuity of care, all plans will use the same PA criteria, step therapy edits, and quantity limits developed by HCA.
If you can't find the drug you are looking for on the Apple Health PDL, contact the managed care plan. For the FFS plan, see the FFS plan only coverage lists below.
- Apple Health PDL 10/22/2021 - 10/28/2021
- Apple Health PDL 10/15/2021 - 10/21/2021
- Apple Health PDL 10/8/2021 - 10/14/2021
- Apple Health PDL 10/1/2021 - 10/7/2021
- Apple Health PDL 9/24/2021 - 9/30/2021
- Apple Health PDL 9/17/2021 - 9/23/2021
- Apple Health PDL 9/10/2021 - 9/16/2021
- Apple Health PDL 9/3/2021 - 9/9/2021
- Apple Health PDL 8/27/2021 - 9/2/2021
- Apple Health PDL 8/5/2021 - 8/26/2021
- Apple Health PDL 7/1/2021 - 8/4/2021
- Apple Health PDL 6/4/2021 - 6/30/2021
- Apple Health PDL 5/7/2021 - 6/3/2021
- Apple Health PDL 4/2/2021 - 5/6/2021
- Apple Health PDL 3/5/2021 - 4/1/2021
- Apple Health PDL 2/5/2021 - 3/4/2021
- Apple Health PDL 1/8/2021 - 2/4/2021
- Apple Health PDL 12/4/2020 - 1/7/2021
Preferred drug lists (PDL)
The Apple Health (Medicaid) Fee-For-Service Preferred Drug List no longer applies. All PDL products are on HCA’s Apple Health Preferred Drug List that is used by managed care plans and the fee-for-service program.
If you can't find the versions you're looking for, email us firstname.lastname@example.org.
The therapeutic interchange program (TIP) will apply only to drug classes included in both the Washington PDL and the Apple Health PDL. Therapeutic interchange is a service for Endorsing Practitioners of the Washington PDL.
- Over-the-counter products:
- Covered over-the-counter products are now listed on HCA’s Apple Health Preferred Drug List.
- Cough and cold products:
- Covered cough and cold products are listed on HCA’s Apple Health Preferred Drug List.
- Drugs for Part D dual eligible clients
- Drugs billed under miscellaneous HCPCS codes that require prior authorization
- Drugs administered to managed care clients but reimbursed through fee-for-service
Note: For information on billing and rates, the Apple Health PDL, and expedited authorization codes, please visit the Prescription Drug Program on our provider billing guide and rates webpage.